Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment

Cytometry Part B - Clinical Cytometry

Volumn 70, Issue 5, 2006, Pages 329-334

  Qadir, Misbah ^a   Barcos, Maurice ^a   Stewart, Carleton C ^a   Sait, Sheila N J ^a   Ford, Laurie A ^a   Baer, Maria R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acute leukemia; Immunophenotyping; Multiparameter flow cytometry

Indexed keywords

ACUTE LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRUCTURE; CYTOCHEMISTRY; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOID CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANTIGENS, CD; CELL LINEAGE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33749556920     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20112     Document Type: Article

References (20)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 1991;78:325-329.
3. O'Donnell MR, Appelbaum FR, Baer MR, Byrd JC, Coutre SE, Damon LE, Erba HP, Estey E, Foran J, Lancet J, Maness LJ, Maslak PG, Millenson M, Moore JO, Przepiorka D, Shami P, Smith BD, Stone RM, Tallman MS. Acute myeloid leukemia clinical practice guidelines in oncology. J Natl Compr Cane Netw 2006;4:16-36.
4. Baer MR, Stewart CC, Dodge RK, Leget G, Suie N, Mrozek K, Schiffer CA, Powell BL, Kolitz JE, Moore JO, Stone RM, Davey FR, Carroll AJ, Larson RA, Bloomfield CD. High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 2001;97:3574-3580.
5. Czuczman MS, Dodge RK, Stewart CC, Frankel SR, Davey FR, Powell BL, Szatrowski TP, Schiffer CA, Larson RA, Bloomfield CD. Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and leukemia Group B study 8364. Blood 1999; 93:3931-3939.
6. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;10:1783-1786.
7. ISCN (2005): An international system for human cytogenetic nomenclature. Shaffer LG, Tommerup N, eds. S Karger, Basel 2005.
8. Snower DP, Smith BR, Munz UJ, McPhedran P. Reevaluation of the periodic acid-Schiff stain in acute leukemia with immunophenotypic analyses. Arch Pathol Lab Med 1991;115:346-350.
9. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103:620-625.
10. Charak BS, Advani SH, Karandikar SM, Parikh PM, Nair CN, Das Gupta A, Gopal R, Tapan KS, Nadkarni KS, Kurkure PA. Sudan black B positivity in acute lymphoblastic leukemia. Acta Haematol 1988; 80:199-202.
11. Ngan M, Chien K, Lee S. Sudan black B positivity in acute lymphoblastic leukemia. Mod Pathol 1992;5:68-70.
12. Arber DA, Snyder DS, Fine M, Dagis A, Niland J, Slovak ML. Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia. Am J Clin Pathol 2001;116:25-33.
13. Dohner H, Arthur DC, Ball ED, Sobol RE, Davey FR, Lawrence D, Gordon L, Paul SR, Surana RB, Testa JR. Trisomy 13: A new recurring chromosome abnormality in acute leukemia. Blood 1990;76:1614-1621.
14. Sreekantaiah C, Baer MR, Morgan S, Isaacs JD, Miller KB, Sandberg AA. Trisomy/tetrasomy 13 in seven cases of acute leukemia. Leukemia 1990;4:781-785.
15. Cuneo A, Ferrant A, Michaux JL, Bosly A, Chatelain B, Stul M, Dal Cin P, Dierlamm J, Cassiman JJ, Hossfeld DK, Castoldi G, Van den Berghe H. Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: Study of nine cases. Cancer Genet Cytogenet 1996;92:31-36.
16. Hamblin TJ. Trisomy 12 in CLL revisited. Leuk Res 1997;21:1025-1026.
17. Michiels JJ, Adriaansen HJ, Hagemeijer A, Hooijkaas H, van Dongen JJ, Abels J. TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics. Br J Haematol 1988;68:423-426.
18. Mitelman Database of Chromosome Aberrations in Cancer. Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman.
19. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-458.
20. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, Fonatsch C, Schwarzinger I. The immunophenotype of 325 adult acute leukemias: Relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol 2002;117:380-389.